Vulnerability, distress, and immune response to vaccination in older adults

Brain, Behavior, and Immunity

Volumn 26, Issue 5, 2012, Pages 747-753

  Segerstrom, Suzanne C ^a   Hardy, Jaime K ^a   Evans, Daniel R ^a   Greenberg, Richard N ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Adiposity; Aging; Depression; Distress; Exercise; Inflammation; Influenza vaccination; Stress

Indexed keywords

BETA 2 MICROGLOBULIN; INTERLEUKIN 6;

AGE; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BODY MASS; DISTRESS SYNDROME; EDUCATION; GENDER; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SLEEP QUALITY; VULNERABILITY;

AGED; AGED, 80 AND OVER; AGING; ANTIBODY FORMATION; BODY MASS INDEX; DATA INTERPRETATION, STATISTICAL; DEPRESSION; DRUG THERAPY; EDUCATIONAL STATUS; FEMALE; HUMANS; INDIVIDUALITY; INFLAMMATION; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERLEUKIN-6; MALE; MIDDLE AGED; SEDENTARY LIFESTYLE; SEX CHARACTERISTICS; SLEEP DISORDERS; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; VACCINATION;

EID: 84861964240     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.10.009     Document Type: Article

References (40)

1. Aiken L.S., West S.G. Multiple Regression: Testing and Interpreting Interactions 1991, Sage, Thousand Oaks, CA.
2. Bernstein E.D., Gardner E.M., Aburtyn E., Gross P., Murasko D.M. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine 1998, 16:1722-1731.
3. Beyer W.E., Palache A.M., Lüchters G., Nauta J., Osterhaus A.D. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?. Virus Res. 2004, 103:125-132.
4. Carty C.L., Heagerty P., Nakatama K., McClung E.C., Lewis J., Lum D., Boespflug E., McCloud-Gehring C., Soleimani B.R., Ranchalis J., Bacus T.J., Furlong C.E., Jarvik G.P. Inflammatory response after influenza vaccination in men with and without carotid artery disease. Arterioscler., Thromb., Vasc. Biol. 2006, 26:2738-2744.
5. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24:385-396.
6. 2-microglobulin and C reactive protein concentrations in viral infections. J. Clin. Pathol. 1984, 37:1140-1143.
7. Cranford J.A., Shrout P.E., Iida M., Rafaeli E., Yip T., Bolger N. A procedure for evaluating sensitivity to within-person change: can mood measures in diary studies detect change reliably?. Pers. Soc. Psychol. Bull. 2006, 32:917-929.
8. Enders C.K., Tofighi D. Centering predictor variables in cross-sectional multilevel models: a new look at an old issue. Psychol. Methods 2007, 12:121-138.
9. Falsey A.R., Treanor J.J., Tornieporth N., Capellan J., Gorse G.J. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J. Infect. Dis. 2009, 200:172-180.
10. Friedman E.M., Hayney M.S., Love G.D., Urry H.L., Rosenkranz M.A., Davidson R.J., Singer B.H., Ryff C.D. Social relationships, sleep quality, and interleukin-6 in aging women. Proc. Natl. Acad. Sci. 2005, 102:18757-18762.
11. Gardner E.M., Bernstein E.D., Dran S., Munk G., Gross P., Abrutyn E., Murasko D.M. Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine 2001, 19:4610-4617.
12. Glaser R., Robles T.F., Sheridan J., Malarkey W.B., Kiecolt-Glaser J.K. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch. Gen. Psychiat. 2003, 60:1009-1014.
13. Godin G., Shepard R.J. A simple method to assess exercise behavior in the community. Can. J. Appl. Sport Sci. 1985, 10:141-146.
14. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
15. Hannoun C., Megas F., Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 2004, 103:133-138.
16. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger W.H., Heimovitz H., Cohen H.J., Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 1999, 106:506-512.
17. Jefferson, T., Di Pietranouj, C., Al-Ansary, L.A., Ferroni, E., Thorning, S., Thomas, R.E., 2010. Vaccines for preventing influenza in the elderly (Review). Cochrane Library (Issue 2).
18. Keylock K.T., Lowder T., Leifheit K.A., Cook M., Mariani R.A., Ross K., Kim K., Chapman-Novakofski K., McAuley E., Woods J.A. Higher antibody, but not cell-mediated, responses to vaccination in high physically fit elderly. J. Appl. Physiol. 2007, 102:1090-1098.
19. Kiecolt-Glaser J.K., Glaser R. Measurement of immune response. Measuring Stress: A Guide for Health and Social Scientists 1995, 213-229. Oxford University Press, New York. S. Cohen, R.C. Kessler, L.U. Gordon (Eds.).
20. Kiecolt-Glaser J.K., Glaser R., Gravenstein S., Malarkey W.B., Sheridan J. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc. Natl. Acad. Sci. 1996, 93:3043-3047.
21. Kohut M.L., Arntson B.A., Lee W., Rozeboom K., Yoon K.J., Cunnick J.E., McElhaney J. Moderate exercise improves antibody response to influenza vaccination in older adults. Vaccine 2004, 22:2298-2306.
22. Kohut M.L., Cooper M.M., Nickolaus M.S., Russell D.R., Cunnick J.E. Exercise and psychosocial factors modulate immunity to influenza vaccine in elderly individuals. J. Gerontol.: Med. Sci. 2002, 57A:M557-M562.
23. Krakauer T., Russo C. Serum cytokine levels and antibody response to influenza vaccine in the elderly. Immunopharm. Immunotox. 2001, 23:35-41.
24. Morozink J.A., Friedman E.M., Coe C.L., Ryff C.D. Socioeconomic and psychosocial predictors of interleukin-6 in the MIDUS national sample. Health Psychol. 2010, 29:626-635.
25. Morris A.A., Zhao L., Ahmed Y., Stoyanova N., De Staercke C., Hooper W.C., Gibbons G., Din-Dzietham R., Quyyumi A., Vaccariona V. Association between depression and inflammation - differences by race and sex: the META-Health Study. Psychosom. Med. 2011, 73:462-468.
26. Moynihan J.A., Larson M.R., Treanor J., Duberstein P.R., Power A., Shore B., Ader R. Psychosocial factors and the response to influenza vaccination in older adults. Psychosom. Med. 2004, 66:950-953.
27. O'Connor M.F., Bower J.E., Cho H.J., Creswell J.D., Dimistrov S., Hamby M.E., Hoyt M.A., Martin J.L., Robles T.F., Sloan E.K., Thomas K.S., Irwin M.R. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immunol. 2009, 23:887-897.
28. Papanicoloau D.A., Wilder R.L., Manolagas C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1998, 128:127-137.
29. Rethorst C.D., Moynihan J., Lyness J.M., Heffner K.L., Chapman B.P. Moderating effects of moderate-intensity physical activity in the relationship between depressive symptoms and interleukin-6 in primary care patients. Psychosom. Med. 2011, 73:265-269.
30. Sanders V.M., Kasprowicz D.J., Kohn A.P., Swanson M.A. Neurotransmitter receptors on lymphocytes and other lymphoid cells. Psychoneuroimmunology 2001, 161-196. Academic Press, San Diego, CA. third ed. R. Ader, D.L. Felton, N. Cohen (Eds.).
31. Segerstrom S.C., Schipper L.J., Greenberg R.N. Caregiving, repetitive thought, and immune response to vaccination in older adults. Brain Behav. Immunol. 2008, 22:744-752.
32. Snijders T., Bosker R. Multilevel Analysis 1999, Sage, London.
33. Steptoe A., O'Donnell K., Badrick E., Kumari M., Marmot M. Neuroendocrine and inflammatory factors associated with positive affect in healthy men and women: the Whitehall II study. Am. J. Epidemiol. 2008, 167:96-102.
34. Trzonkowski P., MyŚliwska J., Godlewska B., Szmit E., Łukaszuk K., Wieckiewicz J., Brydak L., Machała M., Landowsky J., MyŚliwski A. Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain Behav. Immunol. 2004, 18:135-148.
35. Tsai M.Y., Hanson N.Q., Straka R.J., Hoke T.R., Ordovas J.M., Peacock J.M., Arends V.L., Arnett D.K. Effect of influenza vaccine on markers of inflammation and lipid profile. J. Lab. Clin. Med. 2005, 145:323-327.
36. Vedhara K., Cox N.K.M., Wilcock G.K., Perks P., Hunt M., Anderson S., Lightman S.L., Shanks N.M. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999, 353:627-631.
37. Webster R.G. Immunity to influenza in the elderly. Vaccine 2000, 18:1686-1689.
38. Woods J.A., Keylock K.T., Lowder T., Vieira V.J., Zelkovich W., Dumich S., Colantuano K., Lyons K., Leifheit K., Cook M., Chapman-Novakofski K., McAuley E. Cardiovascular exercise training extends influenza vaccine sero protection in sedentary older adults: the immune function intervention trial. J. Am. Geriatrics Soc. 2009, 57:2183-2191.
39. Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M., Leirer, V.O., 1982-1983. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiat. Res. 17, 37-49.
40. Zissis M., Afroudakis A., Glanopoulos G., Palermos I., Boura X., Michopoulos S., Archimandritis A. B2 microglobulin: is it a reliable marker of activity in inflammatory bowel disease?. Am. J. Gastroentorol. 2001, 96:2177-2183.